Alliance Pharma PLC has received a notification of major holdings from Rathbones Investment Management Ltd. The reason for the notification is an acquisition or disposal of voting rights. The shareholder, Rathbones Investment Management Ltd, is based in London, United Kingdom. The notification was made on 11th October 2023, and the threshold was crossed or reached on 6th October 2023.
The resulting situation on the date the threshold was crossed or reached is as follows: Rathbones Investment Management Ltd holds 4.807500% of the voting rights attached to shares, which amounts to 25,968,567 voting rights in Alliance Pharma PLC. This is a decrease from the previous position of 5.411400% of voting rights.
The notification also provides information on the full chain of controlled undertakings through which the voting rights and/or financial instruments are effectively held. Rathbones Investment Management Limited, a controlled undertaking of Rathbones Group Plc, holds 3.475600% of voting rights in Alliance Pharma PLC. Investec Wealth & Investment Limited, another controlled undertaking of Rathbones Group Plc, holds 1.331900% of voting rights.
The notification also mentions that the report was delayed due to an IT reporting issue, which has now been resolved. The notification was completed on 11th October 2023.
This information was provided by Euroland.com.